| Disease | Enchondroma |
| Note | Fig: Enchondroma in the distal portion of the femur shaft. (courtesy of Dr Henry DeGroot at http://www.drdegroot.com) Enchondroma is usually a solitary benign lesion in intramedullary bone. Usually asymptomatic, it is incidentally discovered as a palpable bony nodule. Rarely, causes soft tissue swelling and pain at the lesion site. Pain can be a sign of pathologic fracture. Both sex are equally affected, and any age group can be involved. It is thought to develop from epiphyseal cartilage rests that subsequently proliferate and slowly enlarge. Approximately 50% of solitary enchondromas are found in the hands, typically in the middle and distal portions of the metacarpals and the proximal portions of the phalanges, 10% in the feet, 20% in the proximal and distal parts of the femur and the proximal part of the humerus. On gross examination, the lesion is well circumscribed and has the pale bluish-gray appearance typical of cartilage. The nonerheditary syndrome of multiple enchondromas or enchondromatosis is known as Ollier's disease. Enchondromatosis associated with soft tissue hemangiomas is known as Maffucci's syndrome. |
| Pathology | Microscopically, enchondroma is hypocellular with few double-nucleated cells without cytologic atypia, but cellularity may vary. There is no permeation of morrow. The matrix does not show any myxoid change. Calcification and ossification are common. Histologic appearance of enchondroma may recall that of a grade-1 chondrosarcoma. The permeation through the cortex into soft tissue must be identified before a diagnosis of chondrosarcoma is made. The chondromas in Ollier disease and Maffucci syndrome may demonstrate a greater degree of cellularity and cytologic atypia, and may be difficult to distinguish from chondrosarcoma. |
| Fig: H&E 20x original magnification of an enchondroma: note lobules of benign cartilage cells and hyaline matrix. (courtesy of Dr Henry DeGroot at http://www.drdegroot.com).
|
| |
| Treatment | No treatment is required for asymptomatic lesions. If fracture occurs it is usually treated with curretage and bone grafting. |
| Evolution | A small percentage of enchondromas will undergo malignant transformation, usually throught a slow process, occurring over decades. It is more common in long bones than short. |
| Prognosis | Prognosis for benign enchondroma is excellent. Solitary lesion in the hand rarely undergoes transformation. It has been suggested that Maffucci¹s syndrome is associated with a very high incidence of malignancy, either in the skeleton or in visceral organs. |
| Disease | Soft-tissue chondroma |
| Note | Soft-tissue chondroma is a benign cartilage-forming tumor,usually arising from tenosynovial sheaths or the soft tissue adjacent to tendons in the hands and feet, usually without any connection to the underlying bone. Predominantly sited in the fingers, it is usually solitary, develops in adults, and may causes pain. It is composed entirely of mature hyaline cartilage. Infrequently, the tumor undergoes secondary changes and may exhibit morphologic features that result in diagnostic difficulty. |
| Pathology | Microscopically, soft-tissue chondromas vary considerably in appearence. Most consist of hyaline cartilage arranged in lobular pattern, and may show focal fibrosis, ossification, or myxoid change. Diffuse calcification may occur, completely obscuring the cartilagineous nature of the lesion. In some variants, the cartilage matrix becomes extensively mineralized, often associated with necrosis of chondrocytes, causing the tumor to resemble tumoral calcinosis. Hyaline cartilage may also undergo enchondral ossification, mimicking an osteogenic neoplasm or a reactive lesion. Myxoid degeneration may create confusion with extraskeletal myxoid chondrosarcoma. |
| Treatment | Local surgery is the treatment of choice. |
| Clonal karyotypic aberrationsin enchondromas. |
| Bridge JA, Persons DL, Neff JR, Bhatia P. |
| Cancer Detect Prev 1992; 16: 215-219. |
| PMID 1458512 |
| |
| Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesions. |
| Bridge JA, Bhatia PS, Anderson JR, Neff JR. |
| Cancer Genet Cytogenet 1993; 69: 79-90. |
| PMID 8402563 |
| |
| Rearrangement of band q13 on both chromosomes 12 in a periosteal chondroma. |
| Mandahl N, Willen H, Rydholm A, Heim S, Mitelman F. |
| Genes Chromosomes Cancer 1993; 6: 121-123. |
| PMID 7680888 |
| |
| Rearrangement of band q13 on both chromosomes 12 in a periosteal chondroma |
| Shadan FF, Mascarello JT, Newbury RO, Dennis T, Spallone P, Stock AD. |
| Cancer Genet Cytogenet. 2000; 118 :144-147. |
| PMID 10748295 |
| |
| The Cytogenetics of bone and soft tissue tumors. |
| Sandberg AA Bridge JA. |
| Austin: R.G. Landes Company; 1994 |
| |
| Involvement of chromosomes 6 and 11 in a soft tissue chondroma. |
| Dal Cin P, Qi H, Sciot R, Van den Bergh H. |
| Cancer Genet Cytogenet 1997; 93: 177-178. |
| PMID 9078305 |
| |
| Solitary enchondroma with clonal chromosomal abnormalities. |
| Gunawan B, Weber M, Bergmann F, Wildberger J, Fuzesi L. |
| Cancer Genet Cytogenet 1998; 104: 161-164. |
| PMID 9666812 |
| |
| Maffucci's syndrome: clinical and radiological features of a rare condition |
| McDermott AL, Dutt SN, Chavda SV, Morgan DW. |
| J Laryngol Otol. 2001; 115: 845-847. |
| PMID 11668006 |
| |
| Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. |
| Tallini G, Dorfman H, Brys P, Dal Cin P, de Wever I, Fletcher CD, Jonson K, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Samson I, Sciot R, Van den Bergh H, Vanni R, Willen H. |
| J Pathol 2002; 196: 194-203. |
| PMID 11793371 |
| |
| Cytogenetic findings in benign cartilaginous neoplasms. |
| Buddingh EP, Naumann S, Nelson M, Neffa JR, Birch N, Bridge JA. |
| Cancer Genet Cytogenet 2003; 141: 164-168 |
| PMID 12606137 |
| |
| Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: chondrosarcoma and other cartilaginous neoplasms. |
| Sandberg AA, Bridge JA. |
| Cancer Genet Cytogenet 2003;143: 1-31. |
| PMID 12742153 |
| |